Abide Therapeutics Email Format

BiotechnologyNew Jersey, United States11-50 Employees

Abide Therapeutics is a clinical-stage biotechnology company focused on developing first-in-class inhibitors of the serine hydrolase enzyme family, with an initial emphasis on targets involved in central nervous system signaling. The company uses a platform that enables simultaneous discovery and functional understanding of these enzymes, allowing selective inhibitors to be identified from its proprietary chemical library. Abide is based in Princeton, New Jersey, with an additional presence in La Jolla, California. 

The organization has pursued collaborations to advance its work, including a 2017 partnership with the Tourette Association of America to better understand unmet needs in Tourette syndrome. Positioned within the biotechnology research sector, Abide focuses on CNS signaling targets and the serine hydrolase enzyme family, integrating biology and chemistry to move towards therapeutic candidates.

Sign up for free to view info

Company overview Employee directory